Host: The Japanese Society of Toxicology
Name : The 50th Annual Meeting of the Japanese Society of Toxicology
Date : June 19, 2023 - June 21, 2023
Pharmaceutical R&D has played an extremely important role in improving human health, eradicating diseases, and in prolonging people’s lives. Discovering new medicines requires extensive collaborations among subject matter experts from various disciplines to advance molecules through the many stages of R&D assuring that the right targets and molecules are selected, and clinical development occurs in the appropriate patient population. Typically, it requires approximately 10 years to bring a molecule from benchtop to patients. However, special circumstances such as the emergence of SARS-CoV-2 at the end of 2019 (COVID-19) required the swift development of vaccines and drugs to address the pandemic in a timely manner. This success showcases the capability of modern molecular technologies and close collaborations among pharmaceutical industry, Regulators, Investigators, and patients to meet this challenge with the utmost speed and focus. The deep and diverse expertise from preclinical R&D disciplines were key in achieving these goals.
